Objective: To determine whether high-flow oxygen therapy by nasal cannulae (HFNC) is more effective than a high-flow face mask (HFFM) in severe hypoxemia.
Design: Randomized, single-center, open-labeled, controlled trial.
Setting: University Hospital of Nantes, France.